🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
25 results for “BioNTech”
MedicineActive substanceLicence holderStatus
Comirnaty
EU/1/20/1528/001
Tozinameran BioNTech Manufacturing GmbH
Comirnaty
EU/1/20/1528/002-003
Tozinameran BioNTech Manufacturing GmbH
Comirnaty
EU/1/20/1528/004-005
Tozinameran BioNTech Manufacturing GmbH
Comirnaty
EU/1/20/1528/010
Tozinameran BioNTech Manufacturing GmbH
Comirnaty
EU/1/20/1528/028-031
Tozinameran BioNTech Manufacturing GmbH
COMIRNATY JN.1 10 micrograms/dose concentrate for dispersion for injection children 5 to 11 years
EU/1/20/1528/034
Bretovameran BioNTech Manufacturing GmbH
COMIRNATY JN.1 10 micrograms/dose dispersion for injection children 5 to 11 years
EU/1/20/1528/032-033
Bretovameran BioNTech Manufacturing GmbH
COMIRNATY JN.1 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years
EU/1/20/1528/035
Bretovameran BioNTech Manufacturing GmbH
COMIRNATY JN.1 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years
EU/1/20/1528/036
Bretovameran BioNTech Manufacturing GmbH
Comirnaty JN.1 30 micrograms/dose dispersion for injection
EU/1/20/1528/028-29
Bretovameran BioNTech Manufacturing GmbH
COMIRNATY KP.2 10 micrograms/dose dispersion for injection children 5 to 11 years
EU/1/20/1528/040-041
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 BioNTech Manufacturing GmbH
COMIRNATY KP.2 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years
EU/1/20/1528/042
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 BioNTech Manufacturing GmbH
COMIRNATY KP.2 30 micrograms/dose dispersion for injection adults and adolescents from 12 year
EU/1/20/1528/037-038
COVID-19 mRNA vaccine (nucleoside-modified) BioNTech Manufacturing GmbH
Comirnaty LP.8.1 10 micrograms/dose dispersion for injection
EU/1/20/1528/048-049
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation BioNTech Manufacturing GmbH
COMIRNATY LP.8.1 30 micrograms/dose dispersion for injection
EU/1/20/1528/045-046
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation BioNTech Manufacturing GmbH
Comirnaty LP.8.1 30 micrograms/dose dispersion for injection in pre-filled syringe
EU/1/20/1528/051
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation BioNTech Manufacturing GmbH
Comirnaty LP8.1 30 micrograms/dose dispersion for injection in pre-filled syringe
EU/1/20/1528/047
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation BioNTech Manufacturing GmbH
COMIRNATY Omicron XBB.1.5 10 mcg injection
EU/1/20/1528/024
Tozinameran BioNTech Manufacturing GmbH
COMIRNATY Omicron XBB.1.5 10 micrograms/dose concentrate for dispersion for injection children 5 to 11 years
EU/1/20/1528/021
Tozinameran BioNTech Manufacturing GmbH
COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection children 5 to 11 years
EU/1/20/1528/022
Tozinameran BioNTech Manufacturing GmbH
COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection children 5 to 11 years
EU/1/20/1528/023
Tozinameran BioNTech Manufacturing GmbH
COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years
EU/1/20/1528/026
Raxtozinameran BioNTech Manufacturing GmbH
COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years
EU/1/20/1528/018
Tozinameran BioNTech Manufacturing GmbH
COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years
EU/1/20/1528/019
Tozinameran BioNTech Manufacturing GmbH
COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years
EU/1/20/1528/020
Tozinameran BioNTech Manufacturing GmbH
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.